# Rein Therapeutics Inc. (RNTX): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Rein Therapeutics Inc. (RNTX) is 3/100, ranked against 24,000+ stocks in 35 markets (Quality 21, Value 25, Momentum 19, each scored against its sector).

- StockRank: 3/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 21, Value 25, Momentum 19: each a 0-100 percentile within Healthcare.
- Position: #25,728 overall, #2,560 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 0.5832 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 75K.

Source: https://moatmap.ai/stock/RNTX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker